فهرست مطالب mehri nasiri

Monographie is a research that is (usually) done by an author on a single topic and the result, which is accompanied by a description and details, is presented in the form of a book, article or dissertation. Monographie research was first used by Frederick Lopele in the nineteenth century to describe workers' lives. He published the results of his research in a book entitled Workers of 1855. In Iran, monographie first began with the publication of the book "Orazan" by Jalal Al-Ahmad, then the writing of monographies took a new form. The subject of this article is also dedicated to the monographie of Mohammad Ali Eslami Nadoshan. In this Islamic article, Nadoshan is introduced, his works are classified, and then his most famous works are examined.

Abdominal pain and dyspepsia in the morning are a common and chronic problem in children which are commonly seen in school seasons. Given the high rate of morning abdominal pain, nausea and dyspepsia symptoms in children, their influence on the reaction of the parents, frequent visits to physicians, and impaired children's activities, this study had designed to evaluate and compare different dose of the ranitidine for treatment of nausea and abdominal pain in children 3 to 15 years old. In this interventional and randomized clinical trials, children with complaints of morning nausea and abdominal pain more than two weeks, were selected. Patients were randomly divided into two groups treated with single and two times per day of ranitidine. The two groups were matched for age and sex. Patients at the second and sixth weeks after treatment evaluated for symptoms. Data were analyzed with SPSS-18, and chi-square test. 150 children enrolled in study. 29 were referred for morning nausea, 93 with morning abdominal pain and 28 with both problems. Of those who received a single dose of ranitidine, in 70.7% symptoms improved and completely recovered in 29.3%. In group receiving the drug twice per day, 100% achieved complete recovery. Study had shown that in longer duration of the disease, the response to treatment is decreasing. The results of this study emphasize the use of Ranitidine twice daily rather than single dose. Factors such as age, duration of disease and associated symptoms should be considered when adjusting the dose. Given the prevalence of morning abdominal pain in children and the invasiveness of endoscopy, the preferred method could be treatment with ranitidine and waiting for the response as an initial step for this problem.

Polycystic ovarian syndrome (PCOS) is the most common endocrinological disorders that affect approximately 5-7% of women in reproductive age. There is not any consensus about the efficient in vitro fertilization (IVF) protocol for patients with PCOS. The aim of the present study was to compare the half and one-third dose depot gonadotropin-releasing hormone (GnRH) agonist protocols versus the GnRH antagonist protocol in PCOS patients. In the present study، we retrospectively evaluated 119 infertile women with PCOS. The patients entered in the study in accordance with Rotterdam criteria. According to GnRH analogue used for pituitary suppression، patients were divided into three groups: half and one-third dose depot GnRH agonist protocols and GnRH antagonist protocol. In GnRH agonist protocol، half or one-third dose depot Decapeptyl (1. 875 mg، 1. 25 mg) was injected on 21st day of previous cycle. In GnRH antagonist cycles، cetrotide 0. 25 mg were administered daily when the leading follicles reached 14 mm. All basal and controlled ovarian hyperstimulation (COH) characteristics were analyzed. Basal characteristics including: age، FBS، prolactin، hirsutism، length of menstrual cycle were similar between 3 groups. Statically significant decreases in days of stimulation، number of gonadotrophin ampoules and metaphase II (MII) oocytes were found in GnRH antagonist protocol (P<0. 001، P<0. 001 and P=0. 045)، while the decrease in biochemical pregnancy (P=0. 083) and live birth rate (P=0. 169) wasn''t significant. Number of embryos transferred were similar in the half and one-third dose depot GnRH agonist and GnRH antagonist cycles (P=0. 881). The incidence of OHSS weren''t significantly different between 3 groups (5%، 4. 9% and 12. 8%، P=0. 308). Our study suggest that one-third dose depot GnRH agonist protocol could be a suitable choice for treatment of PCOS because of lower incidence of ovarian hyperstimulation syndrome (OHSS) as compared with half dose depot GnRH agonist and higher pregnancy rate as compared with GnRH antagonist.